LABORATORY CRP OF AMER HLDGS (LH)
US50540R4092 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 434.20M | 419.20M | 1.28B | 2.38B | 1.56B | |||
| Depreciation Amortization | 565.90M | 577.30M | 633.90M | 745.10M | 624.70M | |||
| Income Taxes - Deferred | -99.40M | -78.10M | 18.30M | -75.90M | -47.00M | |||
| Change In Working Capital | -474.00M | -361.90M | -603.40M | -263.70M | -856.90M | |||
| Interest Paid | 222.70M | 221.50M | 197.10M | 194.70M | 216.60M | |||
| Taxes Paid | 195.30M | 206.80M | 504.70M | 1.00B | 500.00M | |||
| Other non cash items | 750.00M | 771.20M | 626.50M | 324.60M | 857.50M | |||
| OPERATING CASH FLOW | 1.18B | 1.33B | 1.96B | 3.11B | 2.14B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -493.50M | -453.60M | -481.90M | -460.40M | -381.70M | |||
| Other Investing Activity | -971.40M | -717.90M | -1.17B | -424.20M | -261.50M | |||
| INVESTING CASH FLOW | -1.46B | -1.17B | -1.65B | -884.60M | -643.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -257.60M | -300.00M | 0.00 | -375.00M | -412.20M | |||
| Stock Issued/Repurchased | -946.50M | -945.60M | -1.05B | -1.62B | -44.10M | |||
| Dividend Paid | -251.70M | -254.00M | -195.20M | N/A | N/A | |||
| Other Financing Activity | 1.45B | 1.44B | -77.60M | -74.00M | -61.10M | |||
| FINANCING CASH FLOW | -10.40M | -59.30M | -1.32B | -2.07B | -517.40M | |||
| Exchange Rate Effect | 4.00M | 9.90M | -24.20M | -7.30M | 8.60M | |||
| CHANGE IN CASH | -294.60M | 106.80M | -1.04B | 151.90M | 983.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.18B | 1.33B | 1.96B | 3.11B | 2.14B | |||
| Capital Expenditure | -493.50M | -453.60M | -481.90M | -460.40M | -381.70M | |||
| FREE CASH FLOW | 683.20M | 874.10M | 1.47B | 2.65B | 1.75B | |||
All data in USD